Clinical trial of nafoxidine in advanced breast cancer
- 1 January 1978
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 4 (2), 123-126
- https://doi.org/10.1002/mpo.2950040207
Abstract
Forty‐nine postmenopausal patients with advanced breast cancer were treated with a nonsteroidal antiestrogen, Nafoxidine. The drug was generally well tolerated with dermatitis being the major toxic effect. A partial response in 12 of 40 patients, or 30%, was achieved with a median duration of response of greater than five months.Keywords
This publication has 6 references indexed in Scilit:
- Antiestrogens and Breast Cancer TreatmentAnnals of Internal Medicine, 1975
- Predicting Response to Endocrine Therapy in Human Breast Cancer: A HypothesisScience, 1975
- Antioestrogens in Treatment of Breast Cancer: Value of Nafoxidine in 52 Advanced CasesBMJ, 1974
- Oestrogen Receptor in Human Breast Cancer Tissue and Response to Endocrine TherapyBMJ, 1973
- Anti-oestrogen Therapy for Breast Cancer: A Trial of Tamoxifen at Two Dose LevelsBMJ, 1973
- Clinical trial of nafoxidine, an oestrogen antagonist in advanced breast cancerEuropean Journal of Cancer (1965), 1972